Double-blind, randomized, parallel-group, dose ranging, multi-center study to evaluate the efficacy and safety of 2.5, 10, 35 and 50 mg AVE7688 once daily, using 100 mg losartan-potassium once daily as calibrator, for 12 months treatment, in patients with mild to moderate hypertension. - ND
100 项与 Aventis Pharma Recherche Developpement 相关的临床结果
0 项与 Aventis Pharma Recherche Developpement 相关的专利(医药)
100 项与 Aventis Pharma Recherche Developpement 相关的药物交易
100 项与 Aventis Pharma Recherche Developpement 相关的转化医学